NASDAQ: CRMD
Cormedix Inc Stock Ownership - Who owns Cormedix?

Insider buying vs selling

Have Cormedix Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alan W. DuntonDirector2025-12-3020,000$13.00
$260.00kSell
Alan W. DuntonDirector2025-12-3020,000$4.03
$80.60kBuy
Joseph TodiscoChief Executive Officer2025-12-1830,000$12.00
$360.00kSell
Joseph TodiscoChief Executive Officer2025-12-1830,000$4.43
$132.90kBuy
Steven W. LefkowitzDirector2025-12-0940,000$11.88
$475.20kSell
Janet DillioneDirector2025-12-0919,000$9.55
$181.45kBuy
Janet DillioneDirector2025-12-0915,000$5.63
$84.45kBuy
Janet DillioneDirector2025-12-0934,000$12.00
$408.00kSell
Janet DillioneDirector2025-12-0215,124$4.43
$67.00kBuy
Janet DillioneDirector2025-12-0219,323$3.55
$68.60kBuy

1 of 5

CRMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRMD insiders and whales buy or sell their stock.

CRMD Shareholders

What type of owners hold Cormedix Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc7.22%5,688,303$69.17MInstitution
Vanguard Group Inc5.05%3,977,658$48.37MInstitution
Marshall Wace LLP4.41%3,473,494$42.24MInstitution
Deerfield Management Company LP4.22%3,323,833$40.42MInstitution
Gary A. Gelbfish3.48%2,739,743$33.32MInsider
State Street Corp2.33%1,835,621$22.32MInstitution
Geode Capital Management LLC2.30%1,809,772$22.01MInstitution
Citadel Advisors LLC2.18%1,717,087$20.88MInstitution
Alyeska Investment Group LP1.60%1,262,979$15.36MInstitution
Ubs Group Ag1.38%1,090,908$13.27MInstitution

1 of 3

CRMD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRMD54.72%8.62%Net SellingNet Selling
MDXG46.43%53.57%Net BuyingNet Selling
ALMS74.71%25.12%Net BuyingNet Buying
BBOT62.58%37.42%Net Buying
ELVN49.49%50.51%Net SellingNet Selling

Cormedix Stock Ownership FAQ

Who owns Cormedix?

Cormedix (NASDAQ: CRMD) is owned by 54.72% institutional shareholders, 8.62% Cormedix insiders, and 36.66% retail investors. Gary A. Gelbfish is the largest individual Cormedix shareholder, owning 2.74M shares representing 3.48% of the company. Gary A. Gelbfish's Cormedix shares are currently valued at $33.32M.

If you're new to stock investing, here's how to buy Cormedix stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.